Library

Home > Library > AYA analytic report on the top tech titans (MAMGA) May 2022

AYA analytic report on the top tech titans (MAMGA) May 2022

Author Peter Prince

Our fintech finbuzz analytic report shines fresh light on the fundamental prospects of U.S. tech titans Meta, Apple, Microsoft, Google, and Amazon (aka M.A.M.G.A.). As of Spring-Summer 2022, this macro report focuses on the global supply chain issues and semiconductor microchip shortages in response to persistent demands of U.S. tech titans. The extant semiconductor microchip demand-supply imbalance remains severe for the U.S. tech and auto industries. It can take several years for the major semiconductor microchip manufacturers to build out new capacity during the current boom-bust business cycle. We expect adequate microchip supplies to meet tech and auto demands in 2023-2024 as the prevalent semiconductor capital investments bear fruit in due course. This macro trend has profound public policy implications for U.S. tech titans Meta, Apple, Microsoft, Google, and Amazon.

Description:

Our fintech finbuzz analytic report shines fresh light on the fundamental prospects of U.S. tech titans Meta, Apple, Microsoft, Google, and Amazon (aka M.A.M.G.A.). As of Spring-Summer 2022, this macro report focuses on the global supply chain issues and semiconductor microchip shortages in response to persistent demands of U.S. tech titans. The extant semiconductor microchip demand-supply imbalance remains severe for the U.S. tech and auto industries. It can take several years for the major semiconductor microchip manufacturers to build out new capacity during the current boom-bust business cycle. We expect adequate microchip supplies to meet tech and auto demands in 2023-2024 as the prevalent semiconductor capital investments bear fruit in due course. This macro trend has profound public policy implications for U.S. tech titans Meta, Apple, Microsoft, Google, and Amazon.

 

AYA fintech network platform provides proprietary alpha stock signals and personal finance tools for U.S. stock market investors and traders. Our quantitative analysis accords with the standard approach to discounting-cash-flows (DCF) and free-cash-flows (FCF) corporate valuation.

 

This analytic report cannot constitute any form of financial advice, analyst opinion, recommendation, or endorsement. We refrain from engaging in financial advisory services, and we seek to offer our analytic insights into the latest economic trends, stock market topics, investment memes, and other financial issues. Our proprietary alpha investment algorithmic system helps enrich our AYA fintech network platform as a new social community for stock market investors: https://ayafintech.network.

 

We share and circulate these informative posts and essays with hyperlinks through our blogs, podcasts, emails, social media channels, and patent specifications. Our goal is to help promote better financial literacy, inclusion, and freedom of the global general public. While we make a conscious effort to optimize our global reach, this optimization retains our current focus on the American stock market.

 

This analytic report shares new economic insights, investment memes, and stock portfolio strategies through both blog posts and patent specifications on our AYA fintech network platform. AYA fintech network platform is every investor's social toolkit for profitable investment management. We can help empower stock market investors through technology, education, and social integration.

 

Blog+More

Credit supply growth drives business cycle fluctuations and often sows the seeds of their own subsequent destruction.

Fiona Sydney

2018-04-26 07:37:00 Thursday ET

Credit supply growth drives business cycle fluctuations and often sows the seeds of their own subsequent destruction.

Credit supply growth drives business cycle fluctuations and often sows the seeds of their own subsequent destruction. The global financial crisis from 2008

+See More

Bill Gates and Warren Buffett shared their best business decisions in a 1998 panel discussion.

Laura Hermes

2017-11-13 07:42:00 Monday ET

Bill Gates and Warren Buffett shared their best business decisions in a 1998 panel discussion.

Top 2 wealthiest men Bill Gates and Warren Buffett shared their best business decisions in a 1998 panel discussion with students at the University of Washin

+See More

Michel De Vroey delves into the global history of macroeconomic theories from real business cycles to persistent monetary effects.

Laura Hermes

2023-02-07 08:26:00 Tuesday ET

Michel De Vroey delves into the global history of macroeconomic theories from real business cycles to persistent monetary effects.

Michel De Vroey delves into the global history of macroeconomic theories from real business cycles to persistent monetary effects. Michel De Vroey (2016)

+See More

From crony capitalism to state capitalism, what economic policy lessons can we learn from Putin's reign in Russia?

Jonah Whanau

2018-03-13 07:34:00 Tuesday ET

From crony capitalism to state capitalism, what economic policy lessons can we learn from Putin's reign in Russia?

From crony capitalism to state capitalism, what economic policy lessons can we learn from President Putin's current reign in Russia? In the 15 years of

+See More

Citron Research short-sellers initiate a class-action lawsuit against Tesla and its executive chairman Elon Musk.

Monica McNeil

2018-09-05 08:34:00 Wednesday ET

Citron Research short-sellers initiate a class-action lawsuit against Tesla and its executive chairman Elon Musk.

Citron Research short-sellers initiate a class-action lawsuit against Tesla and its executive chairman Elon Musk because he might have deliberately orchestr

+See More

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma.

Daisy Harvey

2019-06-07 04:02:05 Friday ET

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma.

The world seeks to reduce medicine prices and other health care costs to better regulate big pharma. Nowadays the Trump administration requires pharmaceutic

+See More